Patents by Inventor Mark Okusa

Mark Okusa has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS AND COMPOSITIONS FOR TREATING INFLAMMATORY RESPONSE
    Publication number: 20070265440
    Abstract: Compositions for oral administration of compounds having A2A adenosine receptor antagonist activity are provided. These compositions are useful for treatment of inflammatory conditions.
    Type: Application
    Filed: April 24, 2007
    Publication date: November 15, 2007
    Inventors: Joel Linden, Gail Sullivan, Ian Sarembock, Timothy MacDonald, Mark Okusa, Irving Kron, W. Scheld
  • Pharmaceutical compositions having Aadenosine receptor agonist activity
    Patent number: 7226913
    Abstract: The present invention provides compositions for oral administration of compounds having A2A adenosine receptor agonist activity. These compositions are useful for treatment of inflammatory conditions.
    Type: Grant
    Filed: March 3, 2003
    Date of Patent: June 5, 2007
    Assignee: University of Virginia Patent Foundation
    Inventors: Joel M. Linden, Gail W. Sullivan, Ian J. Sarembock, Timothy MacDonald, Mark Okusa, Irving L. Kron, W. Michael Scheld
  • Agonists of A2A adenosine receptors for treatment of diabetic nephropathy
    Publication number: 20050261236
    Abstract: The present invention provides a therapeutic method for treating diabetic kidney disease, e.g., diabetic nephropathy that includes the administration of an effective amount of an A2A adenosine receptor agonist. Optionally, the method includes administration of a type IV PDE inhibitor.
    Type: Application
    Filed: May 3, 2005
    Publication date: November 24, 2005
    Inventors: Mark Okusa, Joel Linden, Timothy Macdonald, Alaa Awad
  • Methods and compositions for treating inflammatory response
    Publication number: 20030162742
    Abstract: Compositions for oral administration of compounds having A2A adenosine receptor antagonist activity are provided. These compositions are useful for treatment of inflammatory conditions.
    Type: Application
    Filed: March 3, 2003
    Publication date: August 28, 2003
    Applicant: University of Virginia Patent Foundation, University of Virginia.
    Inventors: Joel M. Linden, Gail W. Sullivan, Ian J. Sarembock, Timothy MacDonald, Mark Okusa, Irving L. Kron, W. Michael Scheld
  • Methods and compositions for treating inflammatory response
    Patent number: 6531457
    Abstract: Compounds and methods are provided to treat inflammatory conditions with certain A2A adenosine receptor antagonists.
    Type: Grant
    Filed: April 5, 2001
    Date of Patent: March 11, 2003
    Assignees: University of Virginia, University of Virginia Patent Foundation
    Inventors: Joel M. Linden, Gail W. Sullivan, Ian J. Sarembock, Timothy MacDonald, Mark Okusa, Irving L. Kron, W. Michael Scheld
  • Methods and compositions for treating inflammatory response
    Publication number: 20010027185
    Abstract: Compounds and methods are provided to treat inflammatory conditions with certain A2A adenosine receptor antagonists.
    Type: Application
    Filed: April 5, 2001
    Publication date: October 4, 2001
    Applicant: University of Virginia Patent Foundation
    Inventors: Joel M. Linden, Gail W. Sullivan, Ian J. Sarembock, Timothy MacDonald, Mark Okusa, Irving L. Kron, W. Michael Scheld
  • Methods and compositions for treating inflammatory response
    Patent number: 6232297
    Abstract: Compounds and methods are provided to treat inflammatory conditions with certain A2A adenosine receptor antagonists.
    Type: Grant
    Filed: June 15, 1999
    Date of Patent: May 15, 2001
    Assignee: University of Virginia Patent Foundation
    Inventors: Joel M. Linden, Gail W. Sullivan, Ian J. Sarembock, Timothy MacDonald, Mark Okusa